Evidence map›Paper›PMID 32605985›Full record

ArticlemBio2020

The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.

Wooseong Kim, Guijin Zou, Wen Pan, Nico Fricke, Hammad A Faizi, Soo Min Kim, Rajamohammed Khader, Silei Li, Kiho Lee, Iliana Escorba and 4 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Drug Repurposing: An Emerging Strategy inJournal of microbiology and biotechnology · 2025
    Review
  5. Article
  6. Bakuchiol killsFrontiers in pharmacology · 2025
    Article
  7. Article
  8. Article
  9. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  10. Article
  11. Research and development ofRSC medicinal chemistry · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. L007-0069 kills Staphylococcus aureus in high resistant phenotypes.Cellular and molecular life sciences : CMLS · 2022
    Article
  16. Article
  17. Frontiers in cellular and infection microbiology · 2022
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Wooseong KimCollege of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
Guijin ZouInstitute of High Performance Computing, A*STAR, Singapore, Singapore.
Wen PanDivision of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Nico FrickeDepartment of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Hammad A FaiziDepartment of Mechanical Engineering, Northwestern University, Evanston, Illinois, USA.
Soo Min KimCollege of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
Rajamohammed KhaderDivision of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Silei LiDivision of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Kiho LeeDivision of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Iliana EscorbaDivision of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Petia M VlahovskaDepartment of Engineering Sciences and Applied Mathematics, Northwestern University, Evanston, Illinois, USA.
Huajian GaoInstitute of High Performance Computing, A*STAR, Singapore, Singapore.
Frederick M AusubelDepartment of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Eleftherios MylonakisDivision of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA emylonakis@lifespan.org.ORCID 0000-0002-4624-0777
Brown University · USAgency for Science, Technology and Research · SGEwha Womans University · KRNorthwestern University · USHarvard University · USUniversity of Virginia · US

Funding

Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI David C Hooper · 2009 to 2026
$39.4M
NIAID NIH HHS P01 AI083214
6 · The paper itself

Abstract

Resistance or tolerance to traditional antibiotics is a challenging issue in antimicrobial chemotherapy. Moreover, traditional bactericidal antibiotics kill only actively growing bacterial cells, whereas nongrowing metabolically inactive cells are tolerant to and therefore "persist" in the presence of legacy antibiotics. Here, we report that the diarylurea derivative PQ401, previously characterized as an inhibitor of the insulin-like growth factor I receptor, kills both antibiotic-resistant and nongrowing antibiotic-tolerant methicillin-resistant

Indexed as

AminoquinolinesAnimalsAnti-Bacterial AgentsCaenorhabditis elegansDrug SynergismGentamicinsHemolysisHumansLarvaMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular Dynamics SimulationMothsPhenylurea CompoundsStaphylococcal InfectionsStaphylococcus aureusAminoquinolinesAnti-Bacterial AgentsGentamicinsPhenylurea CompoundsPQ 401antibioticantibiotic toleranceantimicrobial resistancebacterial persisterCaenorhabditis elegansmembrane-active agentmembrane-active antimicrobialsMRSApersisters

Identifiers

PMID32605985
PMCPMC7327171
OpenAlexW3040183361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.